Ohio Hemp SB 56 Enforcement: Regulations, Compliance & Industry Impact

Executive Summary

Ohio's Senate Bill 56, which took effect in July 2024, created a regulatory framework for hemp-derived cannabinoid products but has sparked intense controversy over enforcement practices that hemp retailers say unfairly favor the state's licensed marijuana dispensaries. The law established age restrictions, testing requirements, and licensing mandates for hemp products containing intoxicating cannabinoids like delta-8 THC and THCA, but implementation has led to widespread complaints from hemp business owners who report selective enforcement, inconsistent guidance from state agencies, and what they characterize as protectionist policies benefiting Ohio's adult-use cannabis market. As of September 2026, dozens of hemp retailers have faced compliance actions while marijuana dispensaries continue expanding their market share, raising fundamental questions about regulatory equity, interstate commerce protections, and the future of Ohio's dual-market cannabis economy.

The enforcement dispute centers on how the Ohio Department of Commerce Division of Cannabis Control and local law enforcement agencies interpret SB 56's provisions regarding product testing, labeling, and retail licensing. Hemp industry advocates argue that the state has applied stricter scrutiny to hemp retailers than to marijuana dispensaries, despite both selling intoxicating cannabinoid products to adults over 21. The controversy has drawn attention from state legislators, industry trade groups, and legal experts who see Ohio's approach as a test case for how states manage the complex intersection of federal hemp law and state cannabis regulation.

The stakes extend beyond Ohio's borders. With hemp-derived intoxicating products generating an estimated $2.8 billion in national sales during 2025, according to industry analysts, how states enforce hemp regulations affects thousands of small businesses, agricultural producers, and consumers across the country. Ohio's enforcement pattern may influence regulatory approaches in other states grappling with similar market dynamics, making this a pivotal moment for the hemp industry's legal and commercial future.

Why This Matters

The enforcement of Ohio's hemp regulations affects approximately 1,200 hemp retailers statewide, thousands of agricultural producers, and millions of consumers who rely on hemp-derived products for wellness and recreational use. The controversy has significant implications for multiple stakeholder groups and raises fundamental questions about regulatory fairness, market competition, and the boundaries of state authority over hemp commerce.

For hemp business owners, enforcement patterns directly determine their ability to remain operational. Many retailers invested substantial capital in inventory, leases, and compliance infrastructure based on their understanding of SB 56's requirements. Selective or unpredictable enforcement creates existential risk for these businesses, particularly small operators without the legal and financial resources to contest compliance actions. The Ohio Hemp Association reported in August 2026 that 47 member businesses had received cease-and-desist orders or compliance notices since January 2026, with 12 forced to close permanently.

Ohio's licensed marijuana dispensaries represent a different set of interests. The state's adult-use cannabis market, which launched in August 2024, generated approximately $1.1 billion in sales during its first year of operation. Dispensary operators and their investors argue that they operate under significantly more stringent regulatory requirements than hemp retailers, including extensive security measures, track-and-trace systems, and testing protocols that cost millions of dollars to implement. From their perspective, rigorous enforcement of hemp regulations levels a playing field that was previously tilted toward less-regulated competitors.

Agricultural producers occupy a complex middle position. Ohio farmers cultivated approximately 3,400 acres of hemp in 2025, according to the Ohio Department of Agriculture, generating an estimated $18 million in farm-gate revenue. Many growers supply both the compliant hemp CBD market and the more lucrative intoxicating cannabinoid sector. Enforcement uncertainty affects their planting decisions, contract negotiations, and long-term business planning. The Ohio Farm Bureau has called for clearer regulatory guidance to protect agricultural investment.

Consumers face reduced access and higher prices when enforcement actions force retailers to close or limit product selection. Hemp-derived cannabinoids have become popular alternatives to alcohol and pharmaceutical products for millions of Americans, with users citing benefits for anxiety, sleep, and chronic pain management. While marijuana dispensaries offer similar products, they typically charge premium prices due to higher regulatory costs and state excise taxes. The enforcement debate ultimately determines whether Ohio maintains a competitive dual market or consolidates intoxicating cannabinoid sales within the more heavily regulated and taxed dispensary system.

The controversy also carries broader implications for federalism and interstate commerce. The 2018 Farm Bill legalized hemp production and commerce at the federal level, preempting many state restrictions. Ohio's enforcement approach tests the boundaries of state authority to regulate hemp-derived products, potentially setting precedents that affect how other states balance federal hemp law against their own cannabis regulatory frameworks. Legal challenges to Ohio's enforcement practices could reshape the national hemp industry's operating environment.

Background and History

Ohio's current hemp enforcement controversy emerged from a complex legislative and regulatory history spanning nearly a decade, beginning with federal hemp legalization and culminating in the state's attempt to regulate an industry that had already established deep market presence.

Federal Hemp Legalization and Early Ohio Response (2014-2019)

The 2014 Farm Bill authorized state hemp pilot programs for research purposes, but Ohio did not immediately participate. The state's conservative approach to cannabis policy, shaped by decades of prohibition and a cautious legislature, meant Ohio lagged behind early-adopter states like Kentucky and Colorado in developing hemp agriculture. The 2018 Farm Bill fundamentally changed the landscape by removing hemp—defined as cannabis containing no more than 0.3% delta-9 THC by dry weight—from the Controlled Substances Act's Schedule I classification under 21 U.S.C. § 812. This federal legalization preempted state prohibitions and opened interstate commerce in hemp and hemp-derived products.

Ohio responded with House Bill 57, signed into law in July 2019, which established a state hemp cultivation program administered by the Ohio Department of Agriculture. The law focused primarily on agricultural production and processing, with minimal attention to retail sales or consumer products. This regulatory gap would prove consequential as the hemp-derived cannabinoid market exploded in subsequent years.

The Rise of Intoxicating Hemp Products (2019-2023)

Between 2019 and 2023, a new category of hemp products emerged that would eventually trigger Ohio's regulatory response. Manufacturers discovered methods to produce intoxicating cannabinoids from legal hemp, including delta-8 THC, delta-10 THC, THC-O, and THCA. These compounds, while chemically similar to the delta-9 THC found in marijuana, were derived from CBD through isomerization or extracted from hemp plants harvested before full maturation. Because the 2018 Farm Bill defined hemp based solely on delta-9 THC concentration, these products occupied a legal gray area—federally legal as hemp derivatives but producing psychoactive effects similar to marijuana.

Ohio's hemp retailers rapidly expanded their offerings of these products, with smoke shops, convenience stores, and dedicated hemp boutiques selling delta-8 gummies, THCA flower, and other intoxicating items to adults without age verification or testing requirements. By 2023, industry estimates suggested Ohio's hemp-derived intoxicating cannabinoid market had reached approximately $400 million in annual sales, rivaling the state's existing medical marijuana program in size.

This market growth occurred against the backdrop of Ohio's evolving marijuana policy. Voters approved medical marijuana through a legislative process in 2016, with the first dispensaries opening in 2019. In November 2023, Ohio voters passed Issue 2, a citizen-initiated statute legalizing adult-use marijuana and requiring the state to begin licensing recreational dispensaries. The marijuana industry and its investors had anticipated capturing the entire intoxicating cannabis market, but hemp products had already established a significant competitive presence.

Senate Bill 56 Development and Passage (2023-2024)

Senate Bill 56 emerged in late 2023 as the legislature's response to the proliferation of intoxicating hemp products. The bill's sponsors, Senator Steve Huffman and Senator Kristina Roegner, framed the legislation as a consumer protection measure addressing concerns about product safety, youth access, and lack of regulatory oversight. However, the bill's development occurred in close coordination with Ohio's marijuana industry, which had lobbied extensively for restrictions on hemp competitors.

The original version of SB 56 would have effectively banned most intoxicating hemp products by imposing delta-9 THC limits so restrictive that delta-8, THCA, and similar compounds would be prohibited. Hemp industry advocates mobilized opposition, arguing that the bill violated federal hemp law and would destroy thousands of small businesses. After intense lobbying from both sides, the legislature modified the bill to create a regulatory framework rather than an outright ban.

The final version of SB 56, passed in December 2023 and signed by Governor Mike DeWine in January 2024, established several key requirements. The law prohibited sales of intoxicating hemp products to anyone under 21, mandated third-party laboratory testing for potency and contaminants, required child-resistant packaging, imposed labeling standards including cannabinoid content disclosure, and created a licensing system for hemp retailers administered by the Ohio Department of Commerce Division of Cannabis Control. The law also capped delta-9 THC content at 0.3% by dry weight and limited total THC content (including THCA and other isomers) to 15 milligrams per serving for edibles.

Critically, SB 56 included a delayed enforcement provision. While the law took effect in July 2024, the Division of Cannabis Control was given until January 2025 to establish the licensing system and enforcement protocols. This six-month transition period was intended to allow businesses time to achieve compliance, but it also created confusion about which requirements were immediately enforceable.

Implementation and Early Enforcement (2024-2025)

The Division of Cannabis Control published initial guidance in August 2024, but hemp retailers immediately identified ambiguities and inconsistencies. The guidance required testing for a broad panel of cannabinoids, pesticides, heavy metals, and microbial contaminants, but did not specify which laboratories were approved or what testing methodologies were acceptable. Labeling requirements referenced standards that had not been formally adopted. The licensing application process was not available until November 2024, two months after the original target date.

Enforcement actions began in earnest in January 2025, when the transition period officially ended. The Division of Cannabis Control, working with local law enforcement and health departments, conducted inspections of hemp retailers across Ohio. According to data obtained through public records requests by the Ohio Hemp Association, inspectors issued 312 compliance notices during the first quarter of 2025, citing violations including unlicensed operation, inadequate testing documentation, improper labeling, and sales of products exceeding THC limits.

Hemp retailers complained that enforcement was inconsistent and often based on interpretations of SB 56 that contradicted the Division's own guidance. Some inspectors demanded testing certificates for every batch of product, while others accepted manufacturer certificates of analysis. Labeling requirements were applied differently across jurisdictions, with some inspectors accepting standard hemp disclaimers while others required specific Ohio-mandated language that had not been finalized in regulation. Multiple retailers reported that inspectors confiscated inventory without providing clear explanations of which products violated which provisions.

The Enforcement Disparity Emerges (2025-2026)

By mid-2025, a pattern had emerged that would become the central focus of hemp industry complaints. While hemp retailers faced aggressive enforcement actions, Ohio's marijuana dispensaries appeared to receive more lenient treatment despite selling similar intoxicating products. Hemp advocates documented several specific disparities. Marijuana dispensaries were allowed to sell products that exceeded the 15-milligram THC limit imposed on hemp edibles, with some dispensary gummies containing 50 or 100 milligrams of THC per serving. Dispensaries were not required to use the same third-party testing laboratories as hemp retailers, instead using in-house or affiliated labs that hemp businesses were prohibited from using. Labeling and packaging requirements for dispensary products were less stringent than those imposed on hemp items.

The Ohio Hemp Association filed a formal complaint with the Division of Cannabis Control in July 2025, alleging discriminatory enforcement and requesting clarification of regulatory standards. The Division responded in September 2025 with a statement that marijuana dispensaries operate under a different statutory framework—Ohio Revised Code Chapter 3780 for adult-use cannabis versus the hemp provisions in ORC 928—and therefore different standards apply. This response intensified hemp industry frustration, as advocates argued that consumers could not distinguish between intoxicating products based on their regulatory classification and that the dual standard created an unlevel playing field.

The controversy escalated in early 2026 when several high-profile enforcement actions targeted prominent hemp retailers. In February 2026, the Division of Cannabis Control ordered Cleveland-based hemp chain Great Lakes Hemp to cease sales at all 14 Ohio locations, citing inadequate testing documentation and unlicensed operation. The company contested the action, arguing that it had submitted license applications months earlier and that the Division had failed to process them in a timely manner. In April 2026, Columbus police raided three hemp shops in a coordinated operation, seizing approximately $200,000 in inventory and arresting two store owners on charges of trafficking in marijuana—charges based on the theory that THCA flower, which converts to delta-9 THC when heated, should be classified as marijuana rather than hemp.

These enforcement actions generated media attention and legislative scrutiny. State Representative Jamie Callender, who had opposed SB 56 during its passage, held a press conference in May 2026 calling for an investigation into the Division of Cannabis Control's enforcement practices. The Ohio Hemp Association retained legal counsel and began exploring litigation options, including potential federal challenges based on the Supremacy Clause and the Commerce Clause of the U.S. Constitution.

Key Players

The Ohio hemp enforcement controversy involves state regulatory agencies, competing industry groups, legislative actors, and advocacy organizations, each with distinct interests and influence over policy outcomes.

Ohio Department of Commerce Division of Cannabis Control

The Division of Cannabis Control, led by Director James Canepa since its creation in 2024, serves as the primary enforcement authority for both marijuana dispensaries and hemp retailers under SB 56. The Division operates with a budget of approximately $45 million annually, funded primarily through marijuana licensing fees and taxes. Critics argue that this funding structure creates an inherent conflict of interest, as the Division's financial resources depend on the success of the marijuana industry it regulates while simultaneously enforcing restrictions on hemp competitors. Director Canepa has defended the Division's enforcement approach, stating in public remarks that the agency applies consistent standards based on statutory requirements and that any perceived disparities reflect different legal frameworks rather than discriminatory intent.

Ohio Hemp Association

The Ohio Hemp Association represents approximately 400 hemp businesses, including retailers, processors, and agricultural producers. Executive Director Megan Grigsby has been the most visible advocate for hemp industry interests, testifying before legislative committees and organizing opposition to what the association characterizes as overreaching enforcement. The association has documented enforcement actions through member surveys and public records requests, compiling data that forms the basis of complaints about discriminatory treatment. In September 2026, the association announced it had raised $500,000 for a legal defense fund to support members facing enforcement actions and to finance potential litigation challenging Ohio's regulatory approach.

Ohio Cannabis Coalition

The Ohio Cannabis Coalition represents licensed marijuana dispensaries and cultivators, including major multi-state operators like Cresco Labs, Curaleaf, and Verano. The coalition supported SB 56 during its legislative development and has consistently argued that hemp retailers should face the same regulatory requirements as licensed dispensaries. Coalition spokesperson Tom Haren has stated that the organization supports reasonable hemp regulation but opposes what he describes as an unregulated parallel market that undermines the state's carefully constructed cannabis regulatory system. The coalition has lobbied for stricter hemp enforcement and has opposed legislative proposals to ease hemp regulations.

Legislative Actors

State Senator Steve Huffman, a physician and SB 56's primary sponsor, has defended the law as a necessary consumer protection measure while acknowledging that implementation has been imperfect. Senator Huffman has called for the Division of Cannabis Control to provide clearer guidance but has resisted calls to amend the statute. State Representative Jamie Callender has emerged as the hemp industry's leading legislative ally, introducing House Bill 422 in June 2026, which would clarify testing requirements, extend licensing deadlines, and prohibit enforcement actions against retailers who have submitted license applications pending Division review. The bill has been referred to the House Commerce Committee but has not yet received a hearing.

Ohio Attorney General Dave Yost

Attorney General Yost's office provides legal guidance to state agencies and local law enforcement on hemp enforcement questions. The office issued an opinion in March 2025 concluding that THCA flower should be classified as marijuana rather than hemp because it contains total THC exceeding 0.3% when measured after decarboxylation. This opinion has been cited by prosecutors in criminal cases against hemp retailers but has been challenged by defense attorneys who argue it contradicts federal hemp law and the plain language of SB 56. Yost has stated that his office's role is to interpret existing law, not to make policy judgments about the appropriate balance between hemp and marijuana regulation.

Legal and Regulatory Framework

Ohio's hemp enforcement operates within a complex legal structure involving federal preemption principles, state statutory provisions, administrative regulations, and evolving case law that creates significant interpretive challenges.

The foundational federal statute is the Agricultural Improvement Act of 2018, commonly known as the 2018 Farm Bill, which amended the Agricultural Marketing Act of 1946 to define hemp as cannabis containing not more than 0.3% delta-9 THC on a dry weight basis. Section 10113 of the Farm Bill, codified at 7 U.S.C. § 1639o, explicitly preempts state laws that prohibit the interstate transportation or shipment of hemp or hemp products. This preemption provision creates tension with state attempts to restrict hemp-derived intoxicating cannabinoids, as such restrictions may impermissibly burden interstate commerce in federally legal hemp.

Ohio's hemp regulatory authority derives from multiple statutory sources. Ohio Revised Code Chapter 928 governs hemp cultivation and processing, implementing the state's USDA-approved hemp plan. Senate Bill 56 added new provisions to ORC 928.03, establishing age restrictions, testing requirements, and licensing mandates for hemp retailers. Separately, ORC Chapter 3780 governs adult-use marijuana, while ORC Chapter 3796 addresses medical marijuana. These parallel statutory frameworks create the dual regulatory system that hemp advocates argue produces discriminatory enforcement.

The testing requirements under SB 56 mandate that hemp products undergo analysis by an independent, ISO/IEC 17025-accredited laboratory for cannabinoid potency, pesticides, heavy metals, and microbial contaminants. However, the statute does not specify acceptable testing methodologies or performance standards, leaving these critical details to administrative rulemaking. The Division of Cannabis Control published proposed rules in Ohio Administrative Code Chapter 3796:8 in December 2024, but these rules have not been finalized as of September 2026, creating a gap between statutory requirements and enforceable standards.

Labeling requirements under ORC 928.03(D) mandate disclosure of total cannabinoid content, serving size, number of servings per package, and a statement that the product has not been evaluated by the FDA. The statute also requires child-resistant packaging for edibles and prohibits packaging that appeals to children. However, the specific format and placement of required disclosures remain subject to administrative interpretation, leading to inconsistent enforcement.

The licensing system established by SB 56 requires hemp retailers to obtain a license from the Division of Cannabis Control and pay an annual fee of $1,000. The statute specifies that the Division must process license applications within 90 days but does not address what happens if the Division fails to meet this deadline. Multiple retailers have argued that they should not face enforcement actions for unlicensed operation when their applications have been pending for longer than the statutory processing period.

Criminal liability under Ohio law presents additional complexity. ORC 2925.03 prohibits trafficking in marijuana, defined as cannabis containing more than 0.3% delta-9 THC. Prosecutors have charged some hemp retailers under this statute, arguing that THCA flower constitutes marijuana because THCA converts to delta-9 THC when heated. Defense attorneys counter that THCA is not delta-9 THC and that the statute's plain language does not encompass precursor compounds. Several cases are pending in Ohio courts that may resolve this interpretive question.

Federal enforcement policy adds another layer of uncertainty. The Drug Enforcement Administration has not issued definitive guidance on the legal status of delta-8 THC and other hemp-derived intoxicating cannabinoids. The DEA's interim final rule on hemp, published in August 2020, stated that synthetically derived THC remains a Schedule I controlled substance, but the rule did not clarify whether isomerization of CBD to delta-8 THC constitutes synthetic production. This federal ambiguity complicates state enforcement efforts and creates risk for businesses operating in the hemp-derived cannabinoid space.

Market and Business Implications

The enforcement of Ohio's hemp regulations is reshaping the state's cannabis market structure, affecting capital allocation, competitive dynamics, and business model viability across both the hemp and marijuana sectors.

Ohio's licensed marijuana dispensaries have captured increasing market share as hemp enforcement has intensified. According to Division of Cannabis Control sales data, adult-use marijuana sales totaled approximately $1.1 billion in the first year of legal sales from August 2024 to August 2025. Sales accelerated in early 2026, with monthly revenue reaching $120 million in July 2026, a 35% increase from July 2025. Industry analysts attribute part of this growth to consumers shifting from hemp retailers to dispensaries as enforcement actions reduced hemp product availability.

The wholesale hemp market has experienced significant disruption. Ohio hemp processors reported a 40% decline in purchase orders for THCA biomass and delta-8 distillate during the first half of 2026 compared to the same period in 2025, according to data compiled by the Ohio Hemp Association. Wholesale prices for THCA flower fell from approximately $800 per pound in January 2025 to $450 per pound in August 2026, reflecting reduced retail demand and increased inventory as retailers closed or limited product offerings. This price collapse has affected agricultural producers who contracted to grow high-THCA hemp cultivars, with some growers reporting they could not recover production costs.

Multi-state operators in the marijuana sector have benefited from hemp market contraction. Cresco Labs, which operates four dispensaries in Ohio, reported in its second-quarter 2026 earnings call that Ohio revenue increased 28% year-over-year, with management attributing part of the growth to "rationalization of the unregulated hemp market." Curaleaf, operating five Ohio locations, similarly cited favorable competitive dynamics in the state. These companies have invested heavily in Ohio licenses and infrastructure, with capital expenditures totaling tens of millions of dollars per operator, and view strict hemp enforcement as protecting their investment.

Small business impacts have been severe in the hemp sector. The Ohio Hemp Association's September 2026 survey of member businesses found that 47 retailers had closed since January 2026, representing approximately 12% of the association's retail membership. An additional 78 retailers reported they were considering closure due to enforcement uncertainty, compliance costs, or reduced sales. The average hemp retailer employed 4.2 full-time equivalent workers, suggesting that closures have eliminated approximately 200 jobs directly, with additional indirect employment effects in supply chains and service providers.

Compliance costs have emerged as a significant competitive factor. Hemp retailers report that third-party laboratory testing costs between $200 and $400 per batch, depending on the panel of analytes required. A typical hemp shop carrying 50 to 100 distinct products must test each batch, creating monthly testing expenses of $2,000 to $8,000. Licensing fees, legal consultation, and packaging modifications add additional costs. Smaller retailers operating on thin margins have found these expenses prohibitive, while larger chains and well-capitalized operators can absorb the costs more easily, potentially leading to market consolidation.

Investment capital has largely fled the Ohio hemp sector. Venture capital and private equity investors who had funded hemp retail expansion in 2022 and 2023 have redirected capital toward marijuana licenses or exited the Ohio market entirely. One Columbus-based investment fund that had allocated $5 million to hemp retail expansion wrote down its entire Ohio hemp portfolio in the first quarter of 2026, according to investor communications obtained by trade publications. This capital withdrawal limits growth opportunities for remaining hemp businesses and reduces the sector's ability to contest enforcement actions or invest in compliance infrastructure.

The enforcement controversy has also affected ancillary businesses. Payment processors have become more cautious about serving hemp retailers, with several major processors terminating merchant accounts for businesses selling intoxicating hemp products. Landlords have included hemp-restrictive clauses in new commercial leases, concerned about potential enforcement actions affecting their properties. Insurance carriers have increased premiums for hemp retailers or declined coverage altogether, citing regulatory uncertainty.

What Experts Say

Legal scholars, industry analysts, and policy experts have offered divergent assessments of Ohio's hemp enforcement approach, with perspectives shaped by views on federalism, market regulation, and consumer protection priorities.

Professor Douglas Berman of Ohio State University's Moritz College of Law, a nationally recognized expert on drug policy, has characterized Ohio's enforcement pattern as legally vulnerable to federal preemption challenges. According to Berman's analysis published in academic commentary, the 2018 Farm Bill's preemption provision limits state authority to restrict hemp commerce, and Ohio's aggressive enforcement of restrictions on hemp-derived intoxicating cannabinoids may exceed permissible state regulatory authority. Berman has noted that courts have not yet definitively resolved the scope of federal hemp preemption, making Ohio's approach a test case for the boundaries of state power.

Shane Pennington, counsel at Vicente Sederberg LLP and a leading hemp industry attorney, has argued that Ohio's enforcement creates an unconstitutional burden on interstate commerce. In a legal memorandum prepared for the Ohio Hemp Association, Pennington contended that because hemp products are manufactured in multiple states and shipped across state lines, Ohio's testing and labeling requirements that differ from other states' standards impermissibly discriminate against out-of-state commerce. Pennington has suggested that a Commerce Clause challenge to Ohio's regulations could succeed under the doctrine established in cases like Tennessee Wine and Spirits Retailers Association v. Thomas.

Industry analyst Bethany Gomez of Brightfield Group, a cannabis and hemp market research firm, has described Ohio's situation as representative of broader national tensions between hemp and marijuana markets. According to Brightfield's analysis, states with legal marijuana programs have consistently moved toward stricter hemp regulation to protect marijuana tax revenue and licensed operator investments. Gomez has projected that hemp-derived intoxicating cannabinoid sales will decline by 30% to 40% nationally over the next three years as more states implement Ohio-style restrictions, with market share shifting to licensed marijuana dispensaries.

From a public health perspective, Dr. Ryan Vandrey of Johns Hopkins University School of Medicine has emphasized the importance of product testing and quality control regardless of whether products are classified as hemp or marijuana. Vandrey's research has documented significant variability in cannabinoid content and contamination in unregulated hemp products, supporting the rationale for testing requirements. However, Vandrey has also noted that enforcement should focus on consumer protection outcomes rather than market allocation between competing industry sectors.

Ohio Farm Bureau policy counsel Leah Curtis has called for regulatory clarity that protects agricultural interests while addressing legitimate safety concerns. According to Curtis, farmers need consistent standards and market access to justify continued hemp cultivation. The Farm Bureau has advocated for harmonizing hemp and marijuana testing requirements to create a level playing field while preserving hemp's status as an agricultural commodity under federal law.

Consumer advocates have expressed mixed views. Ohio Patients for Medical Marijuana, a patient advocacy organization, has supported strict hemp regulation, arguing that unregulated intoxicating products undermine the medical marijuana program's quality controls and physician oversight. Conversely, the National Organization for the Reform of Marijuana Laws (NORML) has criticized Ohio's enforcement approach as protecting marijuana industry profits at the expense of consumer choice and small business opportunity.

What's Next

The Ohio hemp enforcement controversy will likely evolve through legislative action, litigation, and continued regulatory development over the next 12 to 24 months, with outcomes that could reshape the state's cannabis market structure and influence national hemp policy.

The most immediate development to watch is the fate of House Bill 422, introduced by Representative Jamie Callender in June 2026. The bill would clarify testing requirements, extend licensing deadlines, and prohibit enforcement actions against retailers with pending license applications. The bill has been referred to the House Commerce Committee but has not yet received a hearing. If the bill advances, it would likely face opposition from the marijuana industry and uncertain prospects in the Ohio Senate, where SB 56's original sponsors remain influential. Legislative observers suggest the bill's best chance for passage would be as an amendment to a must-pass budget or omnibus bill later in the 2026 legislative session.

Litigation appears increasingly likely. The Ohio Hemp Association has retained constitutional law specialists and is evaluating potential federal court challenges based on the Supremacy Clause and Commerce Clause. A lawsuit could be filed as early as late 2026, seeking declaratory and injunctive relief against enforcement of SB 56's provisions that allegedly conflict with federal hemp law. Such litigation would likely take 18 to 24 months to resolve through trial and potential appeals, creating continued uncertainty for businesses during the interim.

Several criminal cases involving hemp retailers charged with marijuana trafficking are working through Ohio courts and may produce precedential rulings on the legal status of THCA and other hemp-derived cannabinoids. The most significant case, State v. Martinez in Franklin County Common Pleas Court, involves a Columbus hemp shop owner charged with trafficking for selling THCA flower. The defense has filed a motion to dismiss arguing that THCA is not delta-9 THC and therefore the product is legal hemp under both federal and state law. A ruling is expected in late 2026 or early 2027, with potential appeal to the Ohio Supreme Court depending on the outcome.

The Division of Cannabis Control must finalize administrative rules governing hemp testing, labeling, and licensing. The proposed rules published in December 2024 remain in draft form as of September 2026, with the Division citing the need for additional stakeholder input and technical revisions. Once finalized, the rules will provide clearer standards but may also trigger legal challenges if stakeholders believe the rules exceed statutory authority or conflict with federal law. The Division has indicated it intends to finalize rules by December 2026.

Market consolidation will likely continue regardless of regulatory outcomes. Larger hemp retailers and well-capitalized operators are better positioned to absorb compliance costs and weather enforcement uncertainty, while smaller businesses face continued pressure. Industry analysts project that Ohio's hemp retail sector will shrink by an additional 20% to 30% by mid-2027, with surviving businesses operating under stricter compliance protocols and serving a more limited market niche.

Federal policy developments could dramatically alter the landscape. The Drug Enforcement Administration has indicated it may issue guidance on hemp-derived intoxicating cannabinoids in 2027, potentially clarifying the legal status of delta-8 THC, THCA, and similar compounds. If the DEA determines these products are controlled substances, state enforcement controversies would become moot as federal prohibition would apply. Conversely, if the DEA confirms these products are legal hemp derivatives, states like Ohio would face stronger preemption constraints on their regulatory authority.

The outcome of Ohio's 2026 gubernatorial election may also influence enforcement policy. The Division of Cannabis Control operates under the executive branch, and a new governor taking office in January 2027 could direct changes in enforcement priorities or personnel. Both major-party candidates have been asked about hemp policy during the campaign, with responses suggesting different levels of sympathy for hemp industry concerns.

Further Reading

• Ohio Revised Code Chapter 928 (Hemp Cultivation and Regulation) - https://codes.ohio.gov/ohio-revised-code/chapter-928
• Ohio Revised Code Chapter 3780 (Adult Use Cannabis) - https://codes.ohio.gov/ohio-revised-code/chapter-3780
• Senate Bill 56, 135th Ohio General Assembly - https://www.legislature.ohio.gov/legislation/135/sb56
• Agricultural Improvement Act of 2018 (2018 Farm Bill), Public Law 115-334 - https://www.congress.gov/bill/115th-congress/house-bill/2
• 7 U.S.C. § 1639o (Federal Hemp Preemption Provision) - https://www.law.cornell.edu/uscode/text/7/1639o
• Ohio Department of Commerce Division of Cannabis Control - https://cannabis.ohio.gov
• Ohio Hemp Association - https://www.ohiohemp.org
• DEA Interim Final Rule on Hemp (August 2020) - https://www.federalregister.gov/documents/2020/08/21/2020-18188/implementation-of-the-agriculture-improvement-act-of-2018
• Ohio Attorney General Opinion on THCA Classification (March 2025) - https://www.ohioattorneygeneral.gov/legal/opinions
• House Bill 422, 135th Ohio General Assembly (Hemp